Published on
Apr 17, 2026
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product
STAMFORD, CT--(BUSINESS WIRE)--Apr 17, 2026-- The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three …
Source:
Voice of Alexandria - Minnesota
-
Indeterminate
